Posts tagged as

Prostate Cancer

Study Progress

Patient enrollment in COMPPARE is now closed.  As of 10/31/22, COMPPARE reported a final enrollment of 600 RCT proton participants, 900 pragmatic proton participants, and 1024 photon participants, for a total of 2,524 patients.  …

PCORI Acknowledgements

PCORI Acknowledgement Research reported in this study website was funded through a Patient-Centered Outcomes Research Institute (PCORI) Award (PCS-2017C1-0422).   PCORI Disclaimer The views, statements, and opinions presented in this study website are solely the responsibility of the author(s) and do not necessarily represent the views of the…

Coordinating Center Staff

Day-to-day administration, communications, project management, financial management, and clinical coordination will be managed by the following Coordinating Center staff: Kari Bastow University of Florida Contracting Coordinator     Robin Cacchio, RN, CCRP University of Florida Proton Therapy Institute Director of Research Services…

Patient and Caregiver Stakeholders

The Patient and Caregiver Stakeholders are a diverse group of prostate cancer survivors and caregivers who have worked with the PI, co-PI, and co-investigators to develop this study and help to monitor our progress through quarterly web conferences. Members include: Scott Cielewich Rui Dos Santos (Minority Engagement Group Member) Thomas…

Partner Organizations

The COMPPARE Consortium is proud to partner with the following organizations: 100 Black Men of America 100 Black Men of America’s local chapters prepare young men and women to realize their highest potential.

Site PIs, Co-Investigators, and Researchers

The site principal investigators, co-investigators, and researchers will be responsible for supervision of research staff, protocol development, patient accrual, initial data submission review, analysis of outcomes, and generation of PCORI milestone reports. Mark Artz, PhD UF Health Proton Therapy Institute Physics Co-Coordinator…

ATC

The Advanced Technology Consortium (ATC) will provide an informatics infrastructure and quality assurance process to support the submission, review, and analysis of volumetric imaging and treatment planning data for the COMPPARE study. Leadership of the ATC includes:   Walter Bosch, DSc…

Executive Board

While the PI will have oversight for the design and conduct of the trial, the Executive Board will review all aspects of the study, accrual progress, conflicts, and resolutions, and will provide guidance to the PI. Executive Board members include: Nancy Mendenhall, MD University of…

COMPPARE Newsletter: Summer 2020

A Message from Dr. Nancy Mendenhall As we continue our important work for COMPPARE, we have joined national organizations in developing procedures to treat patients with prostate cancer and other malignancies safely during the COVID-19 outbreak. In addition, we are collaborating with our sites to strengthen their…

Contact the COMPPARE Team